Heng-Li Chen

Title: The Innovative Contributions of Heng-Li Chen

Introduction

Heng-Li Chen is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of antimicrobial peptides, showcasing his expertise through various patents. With a total of 3 patents, Chen continues to push the boundaries of scientific research and innovation.

Latest Patents

Chen's latest patents include a modified antimicrobial peptide derived from an arginine-rich domain. This antimicrobial peptide comprises 2 to 20 variable domains, each consisting of 2 to 20 consecutive basic amino acids. The variable domains are separated by a variable linker, which can contain 1 to 20 amino acids that are not two or more consecutive basic amino acids. Importantly, the peptide has a maximum length of 100 amino acids. Another notable patent involves antimicrobial peptides derived from the hepatitis B virus core protein arginine-rich domain. This pharmaceutical composition includes an isolated peptide with three or four arginine-rich domains from the carboxy-terminal region of the hepatitis B virus core protein, exhibiting antimicrobial activity, along with a pharmaceutically acceptable carrier.

Career Highlights

Heng-Li Chen is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work at Academia Sinica has allowed him to engage in cutting-edge research and contribute to advancements in the field of antimicrobial peptides.

Collaborations

Chen collaborates with esteemed colleagues, including Chiaho Shih and Pei-Yi Su. These collaborations enhance the research output and foster innovation within their respective fields.

Conclusion

Heng-Li Chen's innovative work in antimicrobial peptides highlights his significant contributions to science and technology. His patents reflect a commitment to advancing healthcare solutions through research and collaboration.